Status:
COMPLETED
Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
Lead Sponsor:
Lanzhou University Second Hospital
Conditions:
Glioblastoma
Eligibility:
All Genders
18+ years
Brief Summary
Evaluating the relationship between prostate-specific membrane antigen positron emission tomography and arterial spin labeling perfusion imaging, and the correlation with prostate-specific membrane an...
Eligibility Criteria
Inclusion
- Newly diagnosed or recurrent glioblastoma;
- Adult (≥18 years old);
Exclusion
- The patient has a serious underlying disease or mental illness and is unable to cooperate with the imaging examination;
- Have received systematic chemotherapy;
- The image data is of poor or incomplete quality;
- pregnant women;
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06600399
Start Date
October 1 2022
End Date
February 29 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Hospital of Lanzhou University
Lanzhou, Gansu, China, 730000